MHA FPX 5028 Assessment 3 Best Practices Report  

Best Practices Report

Prior to 1980, sickle cell disease (SCD) was considered primarily a pediatric complaint, with minimal survival rates. Roughly 30% of children born in the United States with sickle cell anemia (SCA) in 1970 failed before reaching their fifth birthday (Chaturvedi & DeBaun, 2016). Still, significant advancements in netting, treatment, and vaccination have especially enhanced pediatric survival rates. Presently, the median age at death for men and women with SCA in the United States has risen to 42 and 48, respectively (Chaturvedi & DeBaun, 2016). While high-income countries have shown pronounced advancements in mortality rates and quality of life, developing nations, particularly in Sub-Saharan Africa, continue to face challenges in perfecting issues for SCD cases (Thompson et al., 2023). 

Evaluation of Health Care Practices

An area showing promise in enhancing health issues and quality of life for SCD cases lies in assessing healthcare practices in Caribbean nations. These countries parade advanced rates of sickle cell particularity frequency compared to the United States yet demonstrate superior health issues compared to Sub-Saharan Africa. In 2020, the Pan American Health Organization (PAHO) initiated a collaborative effort with the Jamaican Ministry of Health to establish a comprehensive integrated health system delivery network (IHSDN) across primary health centers and hospitals. This action aims to manage habitual conditions, emphasizing electronic health records, pool development, telehealth, health creation, and medicine operation (Pan American Health Organization, n.d.). 

Scalability Assessment

This report assesses the scalability of PAHO’s agreement with Jamaica to extend SIDS practices to low-income countries, especially in Sub-Saharan Africa. It evaluates sharing pivotal performance pointers (KPIs) from both the United States and Jamaica, assaying consumer and organizational implications, as well as implicit provider operation challenges in trouble-predicated constricting versus figure-for-service payment strategies. 

MHA FPX 5028 Assessment 3 Best Practices Report 

Performance Indicators

In 2000, the World Health Organization (WHO) published its first global health ranking report, encompassing various pivotal performance pointers among its member countries. These pointers handle life anticipation, maternal and child mortality, complaint mortality rates, structure, and vaccination rates. Despite challenges in data collection, the first set of implicit SCD quality pointers was published in 2011, comprising 41 criteria distributed across six disciplines (Oyeku & Faro, 2017). Fresh global measures include frequency data and mortality rates across the life cycle (PAHO, 2023). Still, determining the true mortality rate of SCD remains challenging due to associated co-morbidities and complications (Thompson et al., 2023).  

Conclusion

Finally, taking advantage of best practices from countries like Jamaica provides a route to improve the results of SCD patients globally. Through strategic implementation of collaborative efforts and cost-effective intervention, SCD’s burden can be reduced, especially in areas with limited resources.

MHA FPX 5028 Assessment 3 Best Practices Report 

Schütte, S., Acevedo, P. N. M., & Flahault, A. (2018). Health systems around the world—a comparison of existing health system rankings. Journal of Global Health, 8(1), 010407. https://doi.org/10.7189/jogh.08.010407

Thompson, AM, Mchug, T.A., Oron, Ap, Tepley, C., Lannberg, N., Wilchis-Tella, v.m. Global, regional, and national understanding and mortality burden of sickle cell disease, 2000–2021: A systematic analysis from Global Burden 2021. Lancet Hematology, 10 (8), E585-599. https://doi.org/10.1016/S2352-3026(23)00118-7